ongitudinal Changes of Salivary Oxytocin and Salivary Cortisol after Inhalation of Clary Sage Essential Oil Vapors: Preliminary Study
Phase 1
- Conditions
- Pregnant women between 38 and 40 weeks of gestation
- Registration Number
- JPRN-UMIN000017830
- Lead Sponsor
- St. Luke's International University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Experienced prolonged pregnancy 2. Previous caesarian section 3. Recurrent miscarriages (3 consecutive) 4. Medical history of treatment of infertility 5. Planned induced labor or cesarean section 6. Planned analgesia 7. Smokes tobacco 8. Alcoholic 9. Complications of pregnancy 10. Takes medication not to related to gestation 11. Hospital visits for complication not related to gestation 12. Medical history that needs treatment or follow up 13. Some allergies of food or drug 14. Plant allergy or allergic symptoms with aromatherapy 15. Breast feeding child 16. Olfactory disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Salivary oxytocin 10 minutes before intervention and 15, 30, 60 minutes after intervention
- Secondary Outcome Measures
Name Time Method Salivary cortisol 10 minutes before intervention and 15, 30, 60 minutes after intervention, Polymorphisms of oxytocin receptor